Comparison of different phosphorus-containing ligands complexing 68Ga for PET-imaging of bone metabolism

Radiochimica Acta

Volumn 99, Issue 1, 2011, Pages 43-51

  Fellner, M ^a   Riss, P ^a   Loktionova, N ^a   Zhernosekov, K ^a   Thews, O ^a   Geraldes, C F G C ^b   Kovacs, Z ^c   Lukes I ^d   Rosch F ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Bone metastases; Complex formation; Ga 68; Macrocylic ligands; Phosphonates

Indexed keywords

EID: 79951691673     PISSN: 00338230     EISSN: None     Source Type: Journal    
DOI: 10.1524/ract.2011.1791     Document Type: Article

References (31)

1. Greenlee, R. T., Hill-Harmon, M. B., Murray, T., Thun, M.: Cancer Statistics, 2001. CA Cancer J. Clin. 51, 15(2001).
2. Rubens, R. D.: Bone metastases - the clinical problem. Eur. J. Cancer 34, 210(1998).
3. Zettinig, G., Dudczak, R., Leitha, T.: Nuklearmedizinische Diagnostik der Osteomyelitis. J. Mineralstoffwechsel 10, 20(2003).
4. Harmer, C. L., Burns, J. E., Sams, A., Spittle, M.: The value of fluorine-18 for scanning bone tumours. Clin. Radiol. 20, 204(1969).
5. 68Ga for labeling of precursor compounds, WO2006056395.
6. 68Ga-labeled skeletal-imaging agents for positron scintigraphy. J. Nucl. Med. 17, 1003(1976).
7. Su, M., Qiu, Y., Jia, W.: A pilot study of antitumor effect of gallium ethylenediaminetetramethylene phosphonate [Ga (III) - EDTMP] in tumor-bearing rats. Adv. Ther. 22, 297(2005).
8. 68Ga]-EDTMP. Nucl. Med. Biol. 34, 391(2007).
9. 68Ga]-EDTMP formulations. Eur. J. Pharm. Biopharm. 68, 406(2008).
10. Desreux, J. F., Merciny, E., Loncin, M. F.: Nuclear magnetic resonance and potentiometric studies of the protonation scheme of two tetraaza tetraacetic macrocycles. Inorg. Chem. 20, 987(1981).
11. Sherry, A. D., Ren, J., Huskens, J., Brucher, E., Toth, E., Geraldes, C. F. C. G., Castro, M. M. C. A., Cacheris, W. P.: Characterization of lanthanide (III) DOTP complexes: thermodynamics, protonation, and coordination to alkali metal Ions. Inorg. Chem. 35, 4604(1996).
12. Bryden, C. C., Reilley, C. N., Desreux, J. F.: Multinuclear nuclear magnetic resonance study of three aqueous lanthanide shift reagents: complexes with EDTA and axially symmetric macrocyclic polyamino polyacetate ligands. Anal. Chem. 53, 1418(1981).
13. Geraldes, C. F. G. C., Brown III, R. D., Cacheris, W. P., Koenig, S. H., Sherry, A. D., Spiller, M.: Evaluation of polyaza macrocyclic methylene phosphonate chelates of gadolinium ions as MRI contrast agents. Magn. Reson. Med. 9, 94(1989).
14. Rudovsky, J., Kotek, J., Hermann, P., Lukes, I., Mainero, V., Aime, S.: Synthesis of a bifunctional monophosphinic acid DOTA analogue ligand and its lanthanide (III) complexes. A gadolinium (III) complex endowed with an optimal water exchange rate for MRI applications. Org. Biomol. Chem. 3, 112(2005).
15. Kovacs, Z., Sherry, A. D.: A general synthesis of mono-and disubstituted 1, 4, 7-triazacyclononanes. Tetrahedron Lett. 36, 9269(1995).
16. Avery, T. D., Fallon, G., Greatrex, B. W., Pyke, S. M., Taylor, D. K., Tiekink, E. R. T.: Mechanistic investigations on the reaction between 1, 2-dioxines and bulky stabilized phosphorus ylides: an efficient route to closely related cyclopropane stereoisomers. J. Org. Chem. 66, 7955(2001).
17. 177Lu-DOTMP: a viable agent for palliative radiotherapy of painful bone metastasis. Radiochim. Acta 96, 55(2008).
18. 177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation. Appl. Radiat. Isot. 57, 177(2002).
19. 5- complexes. A comparison of lanthanideinduced paramagnetic shifts with the MMX energy-minimized structure. J. Magn. Reson. 97, 290(1992).
20. 5-. Eur. J. Inorg. Chem. 23, 4179(2003).
21. Holleman, A. F., Wiberg, E.: Lehrbuch der Anorganischen Chemie. 101. Auflage, de Gruyter, Berlin, New York (1995).
22. -. Eur. J. Inorg. Chem. 813(2001).
23. Azab, H. A., Abou El-Nour, K. M., Sorror, S. H.: Metal ion complexes containing dipeptides, tripeptides, and biologically important zwitterionic buffers. J. Chem. Eng. Data. 52, 381(2007)
24. Alves, F. C., Donato, P., Sherry, A. D., Zaheer, A., Zhang, S., Lubag, A. J. M., Merritt, M. E., Lenkinski, R. E., Frangioni, J. V., Neves, M., Prata, M. I. M., Santos, A. C., de Lima, J. J. P., Geraldes, C. F. G. C.: Silencing of phosphonate-gadolinium magnetic resonance imaging contrast by hydroxyapatite binding. Inv. Radiol. 38, 750(2003).
25. 153Sm-DOTMP as a potential agent for bone pain palliation. Nucl. Med. Commun. 25, 1169(2004).
26. Kubicek, V., Rudovsky, J., Kotek, J., Hermann, P., Vander Elst, L., Muller, R. N., Kolar, Z. I., Wolterbeek, H. T., Peters, J. A., Lukes, I.: A bisphosphonate monoamide analogue of DOTA: a potential agent for bone targeting. J. Am. Chem. Soc. 127, 16477(2005).
27. 166Ho complexes of 1, 4, 7, 10- tetraazacyclododecane-1, 4, 7, 10-tetrakis (methylphosphonic acid monoethylester) (H4DOTPOEt). J. Inorg. Biochem. 102, 1531(2008).
28. Okamoto, Y.: Accumulation of technetium-99m methylene diphosphonate. Conditions affecting adsorption to hydroxyapatite. Oral Med. Oral Pathol. Oral Radio./Endod. 80, 115(1995)
29. 153Sm-EDTMP stability in vitro and vivo by HPLC. J. Radioanal. Nucl. Chem. 236, 87(1998).
30. 166Ho. Dalton Trans. 9, 1411(1995).
31. Harris, W. R., Pecoraro, V. L.: Thermodynamic binding constants for gallium transferrin. Biochem. 22, 292(1983).